Walleye Capital LLC Hookipa Pharma Inc. Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.71 - $1.97 $812,977 - $2.26 Million
1,145,039 New
1,145,039 $1.01 Million
Q2 2022

Aug 08, 2022
SELL
$1.33 - $2.31 $59,655 - $103,612
-44,854 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.26 - $2.52 $176,769 - $353,538
-140,293 Reduced 75.77%
44,854 $102,000
Q4 2021

Mar 03, 2022
BUY
$2.33 - $5.94 $191,416 - $487,988
82,153 Added 79.76%
185,147 $431,000
Q3 2021

Nov 15, 2021
BUY
$5.89 - $9.35 $606,634 - $962,993
102,994 New
102,994 $607,000

Others Institutions Holding HOOK

# of Institutions
3
Shares Held
677K
Call Options Held
0
Put Options Held
0
View Full List

About HOOKIPA Pharma Inc.

HOOK Quotes by TradingView
  • Ticker HOOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,654,500
  • Market Cap $98.7M
  • Description
  • HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...
More about HOOK
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email